β-catenin contributes to lung tumor development induced by EGFR mutations

The discovery of somatic mutations in epidermal growth factor receptor (EGFR) and development of EGFR tyrosine kinase inhibitors (TKIs) have revolutionized treatment for lung cancer. However, resistance to TKIs emerges in almost all patients and currently no effective treatment is available. Here we...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nakayama, Sohei, Sng, Natasha, Carretero, Julian, Welner, Robert, Hayashi, Yuichiro, Yamamoto, Mihoko, Tan, Alistair J., Yamaguchi, Norihiro, Yasuda, Hiroyuki, Li, Danan, Soejima, Kenzo, Soo, Ross A., Costa, Daniel B., Wong, Kwok-Kin, Kobayashi, Susumu S.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4199914/
https://ncbi.nlm.nih.gov/pubmed/25164010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-14-0184
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires